Oppenheimer & Co »

Crispr Therapeutics shares owned by Oppenheimer & Co

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Oppenheimer & Co from 13F filings

Historical chart of Oppenheimer & Co investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Oppenheimer & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Oppenheimer & Co

Quarter filed Position value Share count Share price at filing
2023-09-30 $999k 22k 45.39
2023-06-30 $1.1M 19k 56.14
2023-03-31 $812k 18k 45.23
2022-12-31 $762k 19k 40.65
2022-09-30 $1.3M 20k 65.33
2022-06-30 $1.1M 18k 60.81
2022-03-31 $1.1M 17k 62.79
2021-12-31 $1.5M 19k 75.81
2021-09-30 $2.3M 21k 111.94
2021-06-30 $2.8M 17k 161.88
2021-03-31 $1.3M 11k 121.87
2020-12-31 $1.4M 9.1k 153.06
2020-09-30 $782k 9.4k 83.63
2020-06-30 $734k 10k 73.47
2020-03-31 $460k 11k 42.44
2019-12-31 $244k 4.0k 61.02
2019-03-31 $259k 7.3k 35.70
2018-09-30 $275k 6.2k 44.34